The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...
1d
Co-Diagnostics to Present on Co-Dx(TM) PCR Platform and AI Integration at Point-of-Care Testing 2025
*The Co-Dx PCR platform (including the Co-Dx PCR Home (TM), Co-Dx PCR Pro (TM), mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is ...
Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Attendees interested in learning more about CoSara products, including the TB and HPV tests on the Company's upcoming Co-Dx PCR platform, are encouraged to stop by at VIROCON 2025. CoSara will be ...
By testing for microbes in termite excrement, researchers can distinguish old droppings from fresh, and whether a colony is ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
The employee testified that Walshe bought items including rugs, several towels, and mats during the first week of January ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...
Data presented was selected for ASH’s exclusive program to highlight the most impactful research submitted for this year’s meetingReal-world data reinforces the value of durable, one-time gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback